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Abstract 
Cranial placodes are thickenings in the ectoderm that give rise to sensory 
organs and peripheral ganglia of the vertebrate head. At gastrula and neurula 
stages, placodal precursors are intermingled in the neural plate border with future 
neural and neural crest cells. Here, we show that the epigenetic modifier, DNA 
methyl transferase (DNMT) 3A, expressed in the neural plate border region, 
influences development of the otic placode which will contribute to the ear. 
DNMT3A is expressed in the presumptive otic region at gastrula through neurula 
stages and later in the otic placode itself. Whereas neural plate border and non-
neural ectoderm markers Erni, Dlx5, Msx1 and Six1 are unaltered, DNMT3A loss 
of function leads to early reduction in the expression of the key otic placode specifier 
genes Pax2 and Gbx2 and later otic markers Sox10 and Soho1. Reduction of Gbx2 
was first observed at HH7, well before loss of other otic markers. Later, this 
translates to significant reduction in the size of the otic vesicle. Based on these 
results, we propose that DNMT3A is important for enabling the activation of Gbx2 
expression, necessary for normal development of the inner ear. 
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Highlights 
· epigenetic modifier DNMT3A influences development of the otic placode 
· DNMT3A knock down reduces expression of early otic placode specifiers Pax2 
and Gbx2 
· DNMT3A knock down causes a reduction in the size of the otic vesicle 
· DNMT3A acts as a positive regulator of Gbx2 expression during inner ear 
development 
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Introduction 
Cranial ectodermal placodes are thickened epithelial structures in the head 
ectoderm of the early embryo that contribute to sensory organs (ear, eye and 
olfactory epithelium) and major ganglia of the head (trigeminal, epibranchial). All 
placode precursors arise at gastrula and neurula stages from the neural plate 
border region, between prospective neural and non-neural ectoderm, where they are 
intermingled with future neural and neural crest cells (Bhattacharyya and Bronner-
Fraser, 2004; Meulemans and Bronner-Fraser, 2004; Streit and Stern, 1999). 
Temporal and spatial integration of different signals and transcription 
factors defines the neural plate border territory. At neurula stages, mesenchymal 
FGF signaling induces Wnt8a and FGF signaling in neural ectoderm that defines 
the pre-placodal region in the non-neural ectoderm. Several transcription factors 
characteristic of this region are induced, including Dlx family genes, Erni, Sox3, 
Msx1 and Foxi genes (Ekker et al., 1992; Groves and Bronner-Fraser, 2000; Liu et 
al., 2003; Solomon and Fritz, 2002). At late neurula stages, FGF, BMP and WNT 
signaling are thought to segregate fates within the border area by regulating a set of 
transcription factors including Pax7, Snai2, FoxD3, Sox10, Six1/4 and Eya1/2. 
Subsequently, on the basal side, FGF induces otic invagination (Ladher et al., 2010; 
Streit, 2007). 
This complex network of signaling and transcription factors requires tight 
spatiotemporal regulation, as might be provided by epigenetic modifiers. Recently, 
we showed that DNA methylation by DNMT3A promotes neural crest fate while 
inhibiting neural fate (Hu et al., 2012), suggesting a possible role for these epigenetic 
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factors in regulating cell fate decisions at the neural plate border. DNA 
methyltransferases function by recognizing CpG islands and catalyzing the transfer 
of a methyl group to DNA on the C5 position of cytosine (Cheng and Blumenthal, 
2008). Methylation of CpG sites in the promoter region of a gene is thought to 
inhibit its expression, as shown in cancer and stem cells (Altun et al., 2010; Miranda 
and Jones, 2007; Momparler and Bovenzi, 2000). In some cases, DNMTs are also 
thought to activate gene expression by directly methylating gene bodies (Ball et al., 
2009; Lister et al., 2009) or by inhibiting binding of repressors via methylation 
(Bahar Halpern et al., 2014). 
Since DNMT3A is broadly expressed in the neural plate border territory 
from which not only neural crest but also placodal precursors arise, this raised the 
possibility that it may be required for normal placode development. Here, we test 
the function of DNMT3A on formation of the otic placode and early development of 
the ear. The results show that loss of DNMT3A causes loss of early ear markers 
Gbx2 and Pax2 as well as later otic markers Sox10 and Soho1. This leads to later 
defects in the otic placode, suggesting that epigenetic regulation is critical for 
normal ear development. 
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Results 
 
DNMT3A is expressed in presumptive otic region and otic placode 
As a first step in examining the possible relationship between DNMT3A and 
placode development, we performed in situ hybridization at gastrula through 
neurula stages to determine its expression pattern relative to that of ear precursors 
(dashed lines in Fig. 1). We find that DNMT3A is expressed in the neural plate 
border at HH4 (Fig. 1A). While high expression continues in the neural plate, as 
previously shown (Hu et al., 2012), DNMT3A also is expressed laterally in the 
presumptive ear territory at HH6 (Fig. 1B) and HH8 (Fig. 1C). Transverse sections 
reveal that expression is elevated in the ectodermal layer at the stages examined (Fig. 
1A’, B’, C’).  
 
 
Inhibition of DNMT3A reduces the expression of otic placode markers and the size 
of the otic vesicle 
To assess the functional importance of DNMT3A, we performed loss of 
function experiments using a translational blocking morpholino (MO) (Hu et al., 
2012). The morpholino was electroporated into the gastrula stage embryo at HH4 
either targeting one half of the head region or the lateral placode-forming region of 
the embryo. The effects on placode development were examined at subsequent 
developmental stages by in situ hybridization to determine effects on otic marker 
genes. 
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Knock down of DNMT3A caused a down-regulation of the otic placode 
marker Gbx2 very early in the process of placode specification, by HH7 (Fig. 2A, 
A’). At HH9 Gbx2 was markedly down-regulated in the DNMT3A MO treated side 
(Fig. 2B, B’, D). Similar results were obtained for Pax2, another otic placode marker, 
at HH10 (Fig. 2E, E’, F).  
We also noted down-regulation of Sox10 at HH11 after initiation of its 
expression in the otic placode (Fig. S1A, B), similar to its effects on Sox10 expression 
in the neural crest (Hu et al., 2012), and otic expression of Soho1 at HH12 (Fig S1C) 
upon DNMT3A MO treatment. Interestingly, DNMT3A MO knockdown did not 
alter the expression of the epidermal marker Ck19 in the otic region (Fig 2G, G’). 
The early effects on gene expression led to subsequent defects in otic 
development as evidenced by a reduced size of the otic vesicle (Fig. 2C). By the time 
that the morpholino was introduced at HH4, DNMT3A is already expressed. Thus, 
it is likely that some DNMT3A activity persists in the treated embryos due to 
perdurance of already translated protein and stability of resulting DNA methylation, 
likely explaining the semi-penetrant effects on otic vesicle formation. 
To control for the specificity of the DNMT3A morpholino and demonstrate 
that the observed phenotype was not due to off-target effects, we coelectroporated 
the DNMT3A MO with a construct encoding ubiquitously expressed DNMT3A. This 
resulted in a marked rescue of the loss of function phenotype and restored Gbx2 
expression (Fig. 3A, B, D). Over-expression of the DNMT3A rescue construct alone 
did not alter Gbx2 expression (Fig. 3C). 
Altogether these results suggest that DNMT3A is critical for epigenetic 
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regulation of the otic placode formation and normal early development of the inner 
ear. 
 
DNMT3A knockdown does not alter expression of early neural plate border and 
non-neural ectoderm markers  
Because DNMT3A expression is already present at HH4, it is possible that 
loss of Gbx2 and Pax2 in the otic domain might be secondary to abnormalities in the 
formation of the neural plate border. To examine this possibility, we tested whether 
loss of DNMT3A influenced expression of genes important for neural plate border 
specification. The results show that expression of key early neural plate border 
markers Erni and Msx1 (Fig. 4 A, B) and non-neural ectoderm markers Dlx5 and 
Six1 (Fig. 4 C, D) was unaltered when comparing the DNMT3A-MO injected side 
with the contralateral control MO injected side of the same embryo. This suggests 
that loss of the otic fate is not due to a secondary effect on neural plate border 
formation. 
 Mutual repression between Gbx2 and Otx2 has been reported in sensory 
placode formation (Steventon et al., 2012). Therefore we also tested whether 
DNMT3A knock down causes an expansion of Otx2 expression at the expense of 
Gbx2. However, the results revealed no change in Otx2 expression (Fig. 5A). 
Similarly, expression of Sox2 and Sox3, previously shown to be direct targets of 
DNMT3A during neural crest formation (Hu et al., 2012), were unaffected in the 
otic placodal domain at HH9 (Fig. 5B, C).  
FGF signaling from tissues basal to the otic area has been shown to be 
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important for proper otic invagination (Ladher et al., 2010; Streit, 2007). Therefore 
we checked the expression of a downstream effector of FGF signaling, Erm, to 
investigate whether the pre-placodal ectoderm is receiving FGF signals in the 
morphant embryos. Additionally, since canonical WNT signaling is important for 
Gbx2 expression (Li et al., 2009), we checked expression of a downstream repressor, 
Tcf3 (Cole et al., 2008; Kim et al., 2000; Merrill et al., 2004; Yi et al., 2011). We 
picked these markers, because they are both expressed in the region of interest at 
the time when we observe reduced Gbx2 expression upon DNMT3A knock down. 
However, both markers, Tcf3 and Erm, were unaltered upon DNMT3A knock down 
(Fig. S2). 
 Taken together, these results show that loss of DNMT3A selectively effects 
formation of the otic placode domain without influencing neural plate border 
formation. 
  
 10 
Discussion 
 
DNMT3s are essential for de novo methylation during early developmental 
stages (Okano et al., 1999). They play important roles in cancer and disease, but also 
normal aspects of mammalian development (Ehrlich et al., 2008; Linhart et al., 
2007). Many tumor suppressor genes are silenced in a variety of human cancer cells 
by promoter methylation whereas some oncogenes are activated by 
hypomethylation. In tumor cells, excessive levels of DNMT3B bind to the promoter 
region of E-cadherin, reducing adhesion and aggregation, which correlates with 
increased metastasis (Kwon et al., 2010). Several studies demonstrate a role of 
DNMT3 methyltransferases in development. Single DNMT3B null embryos have 
rostral neural tube defects and growth impairment, whereas DNMT3A and 3B 
double mutants are embryonic lethal (Okano et al., 1999).  
Interestingly, alterations in DNA methylation have also been associated with 
several syndromes that cause hearing related problems (Provenzano and Domann, 
2007). For instance DNA hypomethylation has been related with hearing loss in 
patients with ICF syndrome (immunodeficiency, centromere instability, facial 
anomalies) (Robertson et al., 1999; Xie et al., 1999). In this disease, large parts of 
several chromosomes remain unmethylated, which leads to chromosomal 
rearrangements, thereby effecting gene expression (Jeanpierre et al., 1993; Stacey et 
al., 1995). Hearing loss has also been reported in patients with facioscapulohumeral 
muscular dystrophy (FSHD1). Deletions and hypomethylation in the D4Z4 array on 
chromosome 4 seem key events in this disease (van Overveld et al., 2003). 
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These data suggest that DNMT3 methyltransferases have specificity to 
certain genes to influence particular developmental processes during ear 
development. Here we show for the first time an influence of DNMT3A on very 
early stages of inner ear development, during the development of the otic placode. 
 Previous work from our lab has shown that DNMT3A is highly expressed in 
the neural plate border at gastrula stages and, later on, is expressed in neural folds 
and neural crest cells (Hu et al., 2012). Loss of functions experiments further 
revealed that epigenetic modifications were crucial for neural versus neural crest 
cell fate decisions in the neural tube (Hu et al., 2012), such that DNA 
methyltransferase DNMT3A promotes neural crest specification by directly binding 
to and repressing the neural genes Sox2 and Sox3. In contrast, in the developing ear, 
we find that Sox2 and Sox3 are neither expressed earlier nor is their expression 
altered after DNMT3A loss in the otic area. This difference might be explained by 
the possibility that DNMT3A cooperates with different cofactors in different tissues, 
which would go in line with the late onset of Sox2, and Sox3 expression in the otic 
region compared to the early neural tube expression of these two genes. 
The present results show that, in addition to the neural plate border region, 
DNMT3A also is expressed in the pre-placodal domain at gastrula stages and later 
at lower levels in the chick otic placode domain. Selective loss of DNMT3A in the 
otic domain leads to loss of several otic markers, Gbx2, Pax2, Sox10 and Soho1, and 
subsequent reduction of the otic vesicle. This is in agreement with previous findings 
in mouse (Okano et al., 1999). Although the authors did not focus on otic placode 
development in DNMT3A knockout mice, their data suggest a reduction in otic 
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vesicle size in DNMT3A
+/-
, but not DNMT3B
+/-
 mice (Okano et al. 1999, Fig. 3, 
compare D and H). 
In general, DNMTs are thought to act via methylation of CpG islands in the 
promoter region of genes, resulting in inhibition of gene expression. In contrast, the 
present data suggest that DNMT3A acts as a positive regulator of Gbx2 and Pax2, 
either directly or indirectly. A similar mechanism has been described for FoxA2 
activation during endoderm development (Bahar Halpern et al., 2014). This study 
hypothesized that in undifferentiated hESC-derived early endoderm-stage cells, low 
DNA methylation of certain CpG islands enabled binding of repressive proteins. 
Upon differentiation, DNA methylation of these CpG islands caused loss of 
repressor binding, thus leading to activation of FoxA2. 
We propose that a similar mechanism may be invoked in the otic placode, 
such that DNMT3A methylation of CpG islands prevents binding of yet unknown 
repressors, allowing the activation of otic marker expression. Accordingly to this 
model, in the presence of DNMT3A, CpG islands in the putative repressor binding 
sites become methylated, thus preventing repressor binding to the target gene. Loss 
of DNMT3A results in demethylation of these repressor binding sites. In this state, 
the repressors bind and block target gene expression (Fig. 5D). 
In summary, we have interrogated the function of DNMT3A in early ear 
development. Our results place DNMT3A upstream of one of the earliest otic genes 
Gbx2 (Hidalgo-Sanchez et al., 2000; Paxton et al., 2010). Establishing epigenetic 
regulation as a driver of otic specifier expression provides important insights into 
how the chick inner ear is induced. 
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Methods 
Embryos 
Fertilized chicken eggs were incubated at 37°C to the desired stages. 
In situ hybridization 
Embryos were fixed with 4% paraformaldehyde, washed with PBS/0.1% Tween, 
dehydrated in MeOH, and stored at -20°C. Whole-mount in situ hybridization was 
performed as described (Acloque et al., 2008; Wilkinson, 1992). Dioxigenin-labeled 
RNA probes were made from DNA plasmids or ESTs of DNMT3A, Dlx5, Erm, Erni, 
Gbx2, Msx1, Otx2, Pax2, Six1, Sox2, Sox3, Sox10, Soho1, and. Tcf3. Embryos were 
cryo-sectioned at 20 mm. 
 
Electroporation 
Embryos were electroporated at HH 4–5 as described (Sauka-Spengler and 
Barembaum, 2008) using DNMT3AMO1 (over ATG codon) 
(TGGGTGTGTCACTGCTTTCCACCAT) or DNMT3AMO2 (95 nucleotides up- 
stream of ATG) (CAGTGTCCCCACGGCGCTTCCTGCT) (Hu et al., 2012). The 
coding region of DNMT3A (NM001024832.1) (Hu et al., 2012) was cloned into the 
pCI H2B-RFP vector (Betancur et al., 2010) as rescue construct. For each embryo, 
0.6-0.7 mM MO + 0.5 mg/mL DNA was used for knockdown experiments, and 0.6 
mM MO + 1-1.5 mg/mL DNA was used for rescue experiments, except if stated 
otherwise in the text. The MO was targeted to either half of the anterior side of the 
embryo or the presumptive otic region with five 50-msec pulses of 5.2 V at 100-msec 
intervals. No phenotypic difference in the otic area was observed between one and 
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the other injection method. Electroporated embryos were maintained in culture 
dishes with 1 mL of albumen at 37°C and then fixed. 
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Figure Legends 
Fig. 1: DNMT3A is expressed at sites of otic placode formation. DNMT3A 
transcripts are expressed (A) in the neural plate border region (HH 4), (B, C) the 
dorsal neural folds and otic placode (HH 6, 8). Dashed circles indicate position of 
otic precursors/placode. Black lines indicate position of section (A’, B’, C’). Right 
half of embryo is shown for sections. Arrowheads mark the position of the otic 
placode/vesicle. HH, staging after Hamburger and Hamilton. 
 
Fig. 2. Morpholino-mediated knock down of DNMT3A reduces otic marker 
expression and otic vesicle size. DNMT3A MO or control MO were electroporated 
into the right or left half of the embryo, respectively, at HH4. Morpholinos were 
FITC-labeled (green, small insets). (A, A’) Gbx2 RNA expression was reduced in the 
pre-placodal domain at HH7 on the 3A MO electroporated side. Black line indicates 
level of section (A’). (B) At HH9 Gbx2 RNA expression was reduced in the otic 
placode on the 3A MO electroporated side. Black line indicates level of section (B’). 
(C) At HH13 otic vesicle size was reduced on the 3A MO injected side. (D) Graph 
shows quantification of Gbx2 loss of expression phenotype comparing 3A MO 
injected sides (n=18) to control MO or uninjected sides (n=26) at HH9-10. (E) 
 19 
DNMT3A morpholino knock down causes reduced Pax2 RNA expression in the otic 
area. Black line indicates level of section (E’). (F) The graph shows a quantification 
of the Pax2 loss of expression phenotype. Knock down, n=24; control, n=14. 
Arrowheads mark the position of the otic placode/vesicle on the 3AMO 
electroporated side. (G, G’) Expression of epidermal marker Ck19 is unaltered 
upon DNMT3A MO knockdown (n=9). Bar, 50 µm. 
 
Fig. 3. Loss of Gbx2 is rescued by exogenous DNMT3A. Embryos were 
electroporated with DNMT3A MO in combination with (A) empty vector or (B) 
DNMT3A expression construct or (C) embryos were electroporated with control 
MO and DNMT3A expression vector. (D) Graph represents a quantification of 
embryos with a strong, mild or no effect on Gbx2 expression phenotype upon 
DNMT3A MO knock down compared to rescue and overexpression experiments. 
Knockdown, n=9; rescue, n=13; overexpression, n=7. 
 
Fig. 4. Knock down of DNMT3A does not affect expression of early neural plate 
border and non-neural ectoderm markers Msx1, Erni, Dlx5 and Six1. HH4 embryos 
were electroporated with FITC labeled control MO (left side) or DNMT3A MO 
(right side). RNA levels of neural plate border markers (A) Msx1 (n=8/9), (B) Erni 
(8/8) and the non-neural ectoderm markers (C) Dlx5 (n=8/8) and (D) Six1 (n=6/7) 
were not reduced on the DNMT3A MO injected side. Black line indicates level of 
section (A’–D’). Bar, 50 µm. 
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Fig. 5. Otx2, Sox2 and Sox3 expression remains unchanged upon DNMT3A knock 
down. Embryos were injected with 3A MO on the embryonic right side. 
Morpholinos were FITC-labeled (green, small insets). DNMT3A knock down leaves 
(A) Otx2 (n=13/13), (B) Sox2 (n=7/7) and (C) Sox3 (n=7/8) expression unaltered. 
Dashed circles indicate position of otic domain. (D) Model of function of DNMT3A 
during otic development. In presence of DNMT3A, CpG islands in the putative 
repressor binding sites are methylated, preventing repressor binding to the target 
gene. When DNMT3A is decreased, methylation of repressor binding sites is 
reduced or not present. This allows repressors to bind and prevents target gene 
expression. 
 
Fig. S1. Morpholino knock down of DNMT3A reduces otic expression of Sox10 and 
Soho1. DNMT3A MO (FITC-labeled, green, small insets) was electroporated into 
the right half of the embryo at HH4. (A) Sox10 RNA expression was reduced in the 
otic placode at HH11 (arrowhead) upon electroporation of DNMT3A MO1 (n=6/6) 
and DNMT3A MO2 (n=4/5). (B) Soho1 RNA expression was reduced on the 
DNMT3A injected side MO (n=3/3; 1.0 mM concentration). 
 
Fig. S2. Tcf3 and Erm expression are unaltered upon DNMT3A knock down. 
DNMT3A MO or control MO were electroporated into the right or left half of the 
embryo, respectively, at HH4. Morpholinos were FITC-labeled (green, small insets). 
RNA levels of (A) Tcf3 (n=6/6) and (B) Erm (n=5/5) were not reduced on the 
DNMT3A MO injected side. Black line indicates level of section (A’, B’). 
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Arrowheads mark the position of the otic placode/vesicle on the 3AMO 
electroporated side. 
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